Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C

0.0650
+0.00335.35%
Pre-market: 0.06650.0068+11.39%09:21 EDT
Volume:53.07K
Turnover:3.36K
Market Cap:- -
PE:- -
High:0.0725
Open:0.0619
Low:0.0500
Close:0.0617
Loading ...

Company Profile

Company Name:
Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.